ACADIA Pharmaceuticals, Inc. (ACAD)

23.39 +0.89 (+3.96%) USD  |  NASDAQ  |  Mar 04, 16:00
23.49 +0.10 (+0.43%) Pre-Market: 08:10
More

ACADIA Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for ACAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
Agilent Technologies, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade